![](https://developmentalbiology.wustl.edu/wp-content/uploads/2020/02/180315_MM_MorrisWetLab114-1024x683.jpg)
Current research
Our research is highly diverse and includes topics ranging from embryogenesis, cell reprogramming and organogenesis to aging and stem cell engineering.
Our ongoing and future work will focus on new and emerging areas of developmental biology, such as epigenetics and genomics.
![](https://developmentalbiology.wustl.edu/wp-content/uploads/2022/06/Mokalled.jpg)
Model systems
We house one of the largest zebrafish facilities in the world. Along with zebrafish (D. rerio), we study several other model systems, including the fruit fly (D. melanogaster), nematode (C. elegans) and mouse (M. musculus), as well as tissue culture systems and embryonic stem cells.
Latest news
Dr. Aaron DiAntonio has received a three year $1,231,636 award contribution from the National Institute of Neurological Disorders and Stroke
Congratulations to Dr. Aaron DiAntonio! Aaron DiAntonio, Ph.D., Alan A and Edith L Wolff Professor of Developmental Biology, has received a three year $1,231,636 award contribution from the National Institute of Neurological Disorders and Stroke beginning June 2024, for his project entitled “Regulation of axonal degeneration by the DLK kinase”
Dr. Aaron DiAntonio has received a two-year $929,948 grant award from the Department of the Army-USAMRAA
Congratulations to Dr. Aaron DiAntonio! Aaron DiAntonio, Ph.D., Alan A and Edith L Wolff Professor of Developmental Biology, has received a two-year $929,948 grant award from the Department of the Army-USAMRAA beginning May 1, 2024 for his project entitled “Targeting TDP-43 mitochondrial mislocalization in ALS”.
Dr. Aaron DiAntonio and Dr. Jeffrey Milbrandt have received a five-year $3,747,618 grant award from the NIH
Congratulations to Dr. Aaron DiAntonio! Aaron DiAntonio, Ph.D., Alan A and Edith L Wolff Professor of Developmental Biology, and Dr. Jeffrey Milbrandt, (Genetics) have received a five-year $3,747,618 grant award from the NIH/ NINDS beginning April 1, 2024 for their project entitled “The role of SARM1 in neuroinflammation-mediated axonal damage”.